StockDriftsStockDriftsTop 3 Madrona Venture Group, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 53.24% | 6.02M | $12K | +0.00%(+0) | $11.80(-72.46%) | 2025-12-31 | |
| PATH | UIPATH INC | 45.16% | 607.7K | $10K | +0.00%(+0) | $0.00(+17780605.28%) | 2025-12-31 | |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | 1.6% | 42.4K | $353 | +0.00%(+0) | $8.68(-10.31%) | 2025-12-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +20.60% | +75.42% | +3.51% | +18.81% |
| Top 20 Holdings Unweighted | +10.74% | +35.79% | -6.40% | -28.14% |
Madrona Venture Group, Llc reports $22.05K in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are NAUT (53.2%), PATH (45.2%) and DNA (1.6%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +75.42% on a three-year cumulative basis. Figures reflect the Q4 2025 filing.
Sign up free to track Madrona Venture Group, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Madrona Venture Group, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1887785). View Madrona Venture Group, Llc’s 13F filings on SEC